Perrino M, Ahmari N, Hall A, Jackson M, Na Y, Pundavela J
Life Sci Alliance. 2024; 7(5.
PMID: 38458648
PMC: 10923703.
DOI: 10.26508/lsa.202302229.
Raut N, Maile L, Oswalt L, Mitxelena I, Adlakha A, Sprague K
JCI Insight. 2024; 9(2).
PMID: 38258905
PMC: 10906222.
DOI: 10.1172/jci.insight.171275.
Na Y, Hall A, Yu Y, Hu L, Choi K, Burgard J
Oncogene. 2023; 42(13):1038-1047.
PMID: 36759572
PMC: 10194627.
DOI: 10.1038/s41388-023-02620-x.
Anastasaki C, Chatterjee J, Cobb O, Sanapala S, Scheaffer S, Costa A
Acta Neuropathol Commun. 2022; 10(1):120.
PMID: 35986378
PMC: 9392324.
DOI: 10.1186/s40478-022-01428-2.
Harigai R, Sato R, Hirose C, Takenouchi T, Kosaki K, Hirose T
Cancers (Basel). 2022; 14(10).
PMID: 35625983
PMC: 9140047.
DOI: 10.3390/cancers14102377.
Synaptic dysfunction connects autism spectrum disorder and sleep disturbances: A perspective from studies in model organisms.
Doldur-Balli F, Imamura T, Veatch O, Gong N, Lim D, Hart M
Sleep Med Rev. 2022; 62:101595.
PMID: 35158305
PMC: 9064929.
DOI: 10.1016/j.smrv.2022.101595.
MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK.
Na Y, Hall A, Choi K, Hu L, Rose J, Coover R
Oncogene. 2020; 40(5):951-963.
PMID: 33293695
PMC: 7867646.
DOI: 10.1038/s41388-020-01581-9.
Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies.
Oppel F, Tao T, Shi H, Ross K, Zimmerman M, He S
PLoS Genet. 2019; 15(4):e1008039.
PMID: 30970016
PMC: 6476535.
DOI: 10.1371/journal.pgen.1008039.
Genome-wide analysis reveals adaptation to high altitudes in Tibetan sheep.
Wei C, Wang H, Liu G, Zhao F, Kijas J, Ma Y
Sci Rep. 2016; 6:26770.
PMID: 27230812
PMC: 4882523.
DOI: 10.1038/srep26770.
Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.
Li H, Zhao X, Yan X, Jessen W, Kim M, Dombi E
Oncogene. 2015; 35(11):1468-74.
PMID: 26073082
PMC: 4679719.
DOI: 10.1038/onc.2015.207.
Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1.
Jousma E, Rizvi T, Wu J, Janhofer D, Dombi E, Dunn R
Pediatr Blood Cancer. 2015; 62(10):1709-16.
PMID: 25907661
PMC: 4546559.
DOI: 10.1002/pbc.25546.
Polymorphism in the neurofibromin gene, Nf1, is associated with antagonistic selection on wing size and development time in Drosophila melanogaster.
Lee S, Eyre-Walker Y, Rane R, Reuter C, Vinti G, Rako L
Mol Ecol. 2013; 22(10):2716-25.
PMID: 23506114
PMC: 4709439.
DOI: 10.1111/mec.12301.
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.
Jessen W, Miller S, Jousma E, Wu J, Rizvi T, Brundage M
J Clin Invest. 2012; 123(1):340-7.
PMID: 23221341
PMC: 3533264.
DOI: 10.1172/JCI60578.
Decreased bone mineralization in children with Noonan syndrome: another consequence of dysregulated RAS MAPKinase pathway?.
Choudhry K, Grover M, Tran A, OBrian Smith E, Ellis K, Lee B
Mol Genet Metab. 2012; 106(2):237-40.
PMID: 22551697
PMC: 3356458.
DOI: 10.1016/j.ymgme.2012.04.003.
Nf1 limits epicardial derivative expansion by regulating epithelial to mesenchymal transition and proliferation.
Baek S, Tallquist M
Development. 2012; 139(11):2040-9.
PMID: 22535408
PMC: 3347692.
DOI: 10.1242/dev.074054.
Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis.
Miller S, Lan Z, Hardiman A, Wu J, Kordich J, Patmore D
Oncogene. 2009; 29(3):368-79.
PMID: 19901965
PMC: 2809821.
DOI: 10.1038/onc.2009.360.
Ral overactivation in malignant peripheral nerve sheath tumors.
Bodempudi V, Yamoutpoor F, Pan W, Dudek A, Esfandyari T, Piedra M
Mol Cell Biol. 2009; 29(14):3964-74.
PMID: 19414599
PMC: 2704746.
DOI: 10.1128/MCB.01153-08.
Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes.
Farassati F, Pan W, Yamoutpour F, Henke S, Piedra M, Frahm S
Am J Pathol. 2008; 173(6):1861-72.
PMID: 18988803
PMC: 2626396.
DOI: 10.2353/ajpath.2008.080376.
Neurofibromatosis with gastrointestinal stromal tumors: insights into the association.
Cheng S, Huang M, Yang T, Tzen C, Liu C, Liu T
Dig Dis Sci. 2004; 49(7-8):1165-9.
PMID: 15387340
DOI: 10.1023/b:ddas.0000037806.14471.a2.
A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein.
Ratner N, Bloom G, Brady S
J Neurosci. 1998; 18(19):7717-26.
PMID: 9742142
PMC: 6793030.